Importance of oestrogen receptors to preserve functional β-cell mass in diabetes

Nature Reviews Endocrinology

Volumn 8, Issue 6, 2012, Pages 342-351

  Tiano, Joseph P ^a   Mauvais Jarvis, Franck ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLIN; CONJUGATED ESTROGEN; ESTRADIOL; ESTROGEN RECEPTOR; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; FULVESTRANT; G PROTEIN COUPLED RECEPTOR; GESTAGEN; GLUCOSE; LIPID; SELECTIVE ESTROGEN RECEPTOR MODULATOR;

APOPTOSIS; CELL PROTECTION; CELL SURVIVAL; ESTROGEN THERAPY; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RELEASE; INSULIN SYNTHESIS; METABOLIC DISORDER; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PANCREAS ISLET BETA CELL; PANCREAS ISLET TRANSPLANTATION; PRIORITY JOURNAL; RAT STRAIN; REVIEW; SEX DIFFERENCE; STREPTOZOCIN DIABETES;

ANIMALS; DIABETES MELLITUS; DISEASE MODELS, ANIMAL; HUMANS; INSULIN; INSULIN-SECRETING CELLS; LIPID METABOLISM; MICE; RATS; RECEPTORS, ESTROGEN;

EID: 84861335162     PISSN: 17595029     EISSN: 17595037     Source Type: Journal    
DOI: 10.1038/nrendo.2011.242     Document Type: Review

References (131)

1. Mathis, D., Vence, L. & Benoist, C. β-cell death during progression to diabetes. Nature 414, 792-798 (2001).
2. Davalli, A. M. et al. Vulnerability of islets in the immediate posttransplantation period. Dynamic changes in structure and function. Diabetes 45, 1161-1167 (1996). (Pubitemid 26296313)
3. Cattan, P. et al. Early assessment of apoptosis in isolated islets of Langerhans. Transplantation 71, 857-862 (2001). (Pubitemid 32417343)
4. Prentki, M. & Nolan, C. J. Islet β cell failure in type 2 diabetes. J. Clin. Invest. 116, 1802-1812 (2006). (Pubitemid 44033300)
5. Poitout, V. & Robertson, R. P. Glucolipotoxicity: fuel excess and β-cell dysfunction. Endocr. Rev. 29, 351-366 (2008). (Pubitemid 351679704)
6. Eizirik, D. L., Cardozo, A. K. & Cnop, M. The role for endoplasmic reticulum stress in diabetes mellitus. Endocr. Rev. 29, 42-61 (2008). (Pubitemid 351252746)
7. Deroo, B. J. & Korach, K. S. Estrogen receptors and human disease. J. Clin. Invest. 116, 561-570 (2006). (Pubitemid 43326860)
8. Liu, S. & Mauvais-Jarvis, F. Minireview: estrogenic protection of β-cell failure in metabolic diseases. Endocrinology 151, 859-864 (2010).
9. Mauvais-Jarvis, F. Estrogen and androgen receptors: regulators of fuel homeostasis and emerging targets for diabetes and obesity. Trends Endocrinol. Metab. 22, 24-33 (2011).
10. Wynn, V. & Doar, J. W. Some effects of oral contraceptives on carbohydrate metabolism. Lancet 2, 715-719 (1966).
11. Livingstone, C. & Collison, M. Sex steroids and insulin resistance. Clin. Sci. (Lond.) 102, 151-166 (2002). (Pubitemid 34185043)
12. Margolis, K. L. et al. Effect of oestrogen plus progestin on the incidence of diabetes in postmenopausal women: results from the Women's Health Initiative Hormone Trial. Diabetologia 47, 1175-1187 (2004). (Pubitemid 39093314)
13. Kanaya, A. M. et al. Glycemic effects of postmenopausal hormone therapy: the Heart and Estrogen/progestin Replacement Study. A randomized, double-blind, placebo-controlled trial. Ann. Intern. Med. 138, 1-9 (2003). (Pubitemid 36232088)
14. Andersson, B. et al. Estrogen replacement therapy decreases hyperandrogenicity and improves glucose homeostasis and plasma lipids in postmenopausal women with noninsulin-dependent diabetes mellitus. J. Clin. Endocrinol. Metab. 82, 638-643 (1997). (Pubitemid 27068643)
15. Brussaard, H. E., Gevers Leuven, J. A., Frölich, M., Kluft, C. & Krans, H. M. Short-term oestrogen replacement therapy improves insulin resistance, lipids and fibrinolysis in postmenopausal women with NIDDM. Diabetologia 40, 843-849 (1997). (Pubitemid 27306964)
16. Espeland, M. A. et al. Effect of postmenopausal hormone therapy on glucose and insulin concentrations. PEPI Investigators. Postmenopausal Estrogen/Progestin Interventions. Diabetes Care 21, 1589-1595 (1998). (Pubitemid 28449793)
17. Friday, K. E., Dong, C. & Fontenot, R. U. Conjugated equine estrogen improves glycemic control and blood lipoproteins in postmenopausal women with type 2 diabetes. J. Clin. Endocrinol. Metab. 86, 48-52 (2001). (Pubitemid 32109774)
18. Crespo, C. J., Smit, E., Snelling, A., Sempos, C. T. & Andersen, R. E. Hormone replacement therapy and its relationship to lipid and glucose metabolism in diabetic and nondiabetic postmenopausal women: results from the Third National Health and Nutrition Examination Survey (NHANES III). Diabetes Care 25, 1675-1680 (2002). (Pubitemid 41071069)
19. Saglam, K., Polat, Z., Yilmaz, M. I., Gulec, M. & Akinci, S. B. Effects of postmenopausal hormone replacement therapy on insulin resistance. Endocrine 18, 211-214 (2002). (Pubitemid 35239782)
20. Li, C. et al. Low-dose hormone therapy and carbohydrate metabolism. Fertil. Steril. 79, 550-555 (2003). (Pubitemid 36293450)
21. Perera, M. et al. The effects of transdermal estradiol in combination with oral norethisterone on lipoproteins, coagulation, and endothelial markers in postmenopausal women with type 2 diabetes: a randomized, placebo-controlled study. J. Clin. Endocrinol. Metab. 86, 1140-1143 (2001). (Pubitemid 32322994)
22. Cagnacci, A. et al. Effects of low doses of transdermal 17β-estradiol on carbohydrate metabolism in postmenopausal women. J. Clin. Endocrinol. Metab. 74, 1396-1400 (1992).
23. Lindheim, S. R. et al. The route of administration influences the effect of estrogen on insulin sensitivity in postmenopausal women. Fertil. Steril. 62, 1176-1180 (1994). (Pubitemid 24369782)
24. Gale, E. A. & Gillespie, K. M. Diabetes and gender. Diabetologia 44, 3-15 (2001). (Pubitemid 32141879)
25. Godsland, I. F. Oestrogens and insulin secretion. Diabetologia 48, 2213-2220 (2005). (Pubitemid 41618909)
26. Liu, S., Navarro, G. & Mauvais-Jarvis, F. Androgen excess produces systemic oxidative stress and predisposes to β-cell failure in female mice. PLoS ONE 5, e11302 (2010).
27. Fox, H. S. Androgen treatment prevents diabetes in nonobese diabetic mice. J. Exp. Med. 175, 1409-1412 (1992).
28. Pearce, R. B., Formby, B., Healy, K. & Peterson, C. M. Association of an androgen-responsive T cell phenotype with murine diabetes and Idd2. Autoimmunity 20, 247-258 (1995).
29. Rosmalen, J. G. et al. Sex steroids influence pancreatic islet hypertrophy and subsequent autoimmune infiltration in nonobese diabetic (NOD) and NODscid mice. Lab. Invest. 81, 231-239 (2001). (Pubitemid 32176387)
30. Bao, M., Yang, Y., Jun, H. S. & Yoon, J. W. Molecular mechanisms for gender differences in susceptibility to T cell-mediated autoimmune diabetes in nonobese diabetic mice. J. Immunol. 168, 5369-5375 (2002). (Pubitemid 34496006)
31. Puah, J. A. & Bailey, C. J. Insulinotropic effect of ovarian steroid hormones in streptozotocin diabetic female mice. Horm. Metab. Res. 17, 216-218 (1985). (Pubitemid 15062950)
32. Le May, C. et al. Estrogens protect pancreatic β-cells from apoptosis and prevent insulin-deficient diabetes mellitus in mice. Proc. Natl Acad. Sci. USA 103, 9232-9237 (2006). (Pubitemid 43902561)
33. Paik, S. G., Michelis, M. A., Kim, Y. T. & Shin, S. Induction of insulin-dependent diabetes by streptozotocin. Inhibition by estrogens and potentiation by androgens. Diabetes 31, 724-729 (1982). (Pubitemid 12095170)
34. Liu, S. et al. Importance of extranuclear estrogen receptor-α and membrane G protein-coupled estrogen receptor in pancreatic islet survival. Diabetes 58, 2292-2302 (2009).
35. Maclaren, N. K., Neufeld, M., McLaughlin, J. V. & Taylor, G. Androgen sensitization of streptozotocin-induced diabetes in mice. Diabetes 29, 710-716 (1980). (Pubitemid 11026643)
36. Betsholtz, C. et al. Islet amyloid polypeptide (IAPP): cDNA cloning and identification of an amyloidogenic region associated with the species-specific occurrence of age-related diabetes mellitus. Exp. Cell Res. 183, 484-493 (1989). (Pubitemid 19218505)
37. Betsholtz, C. et al. Sequence divergence in a specific region of islet amyloid polypeptide (IAPP) explains differences in islet amyloid formation between species. FEBS Lett. 251, 261-264 (1989). (Pubitemid 19181881)
38. Ohagi, S., Nishi, M., Bell, G. I., Ensinck, J. W. & Steiner, D. F. Sequences of islet amyloid polypeptide precursors of an Old World monkey, the pig-tailed macaque (Macaca nemestrina), and the dog (Canis familiaris). Diabetologia 34, 555-558 (1991).
39. Janson, J. et al. Spontaneous diabetes mellitus in transgenic mice expressing human islet amyloid polypeptide. Proc. Natl Acad. Sci. USA 93, 7283-7288 (1996). (Pubitemid 26243541)
40. Geisler, J. G. et al. Estrogen can prevent or reverse obesity and diabetes in mice expressing human islet amyloid polypeptide. Diabetes 51, 2158-2169 (2002). (Pubitemid 34729021)
41. Kahn, S. E. et al. Oophorectomy promotes islet amyloid formation in a transgenic mouse model of Type II diabetes. Diabetologia 43, 1309-1312 (2000).
42. Lee, Y. et al. Beta-cell lipotoxicity in the pathogenesis of non-insulin-dependent diabetes mellitus of obese rats: impairment in adipocyte-β-cell relationships. Proc. Natl Acad. Sci. USA 91, 10878-10882 (1994).
43. Tiano, J. P. et al. Estrogen receptor activation reduces lipid synthesis in pancreatic islets and prevents β cell failure in rodent models of type 2 diabetes. J. Clin. Invest. 121, 3331-3342 (2011).
44. Nolan, C. J. et al. Beta cell compensation for insulin resistance in Zucker fatty rats: increased lipolysis and fatty acid signalling. Diabetologia 49, 2120-2130 (2006). (Pubitemid 44168480)
45. Garris, D. R. & Garris, B. L. Estrogenic restoration of functional pancreatic islet cytoarchitecture in diabetes (db/db) mutant C57BL/KsJ mice: relationship to estradiol localization, systemic glycemia, and persistent hyperinsulinemia. Cell Tissue Res. 319, 231-242 (2005). (Pubitemid 40174517)
46. Yoshioka, M., Kayo, T., Ikeda, T. & Koizumi, A. A novel locus, Mody4, distal to D7Mit189 on chromosome 7 determines early-onset NIDDM in nonobese C57BL/6 (Akita) mutant mice. Diabetes 46, 887-894 (1997). (Pubitemid 27188269)
47. Wang, J. et al. A mutation in the insulin 2 gene induces diabetes with severe pancreatic β-cell dysfunction in the Mody mouse. J. Clin. Invest. 103, 27-37 (1999). (Pubitemid 29031160)
48. Oyadomari, S. et al. Targeted disruption of the Chop gene delays endoplasmic reticulum stress-mediated diabetes. J. Clin. Invest. 109, 525-532 (2002). (Pubitemid 34171784)
49. Toyoshima, M. et al. Dimorphic gene expression patterns of anorexigenic and orexigenic peptides in hypothalamus account male and female hyperphagia in Akita type 1 diabetic mice. Biochem. Biophys. Res. Commun. 352, 703-708 (2007). (Pubitemid 44880311)
50. Hirosawa, M. et al. Ablation of estrogen receptor α (ERα) prevents upregulation of POMC by leptin and insulin. Biochem. Biophys. Res. Commun. 371, 320-323 (2008).
51. Kawano, K., Hirashima, T., Mori, S. & Natori, T. OLETF (Otsuka Long-Evans Tokushima Fatty) rat: a new NIDDM rat strain. Diabetes Res. Clin. Pract. 24 (Suppl.), S317-S320 (1994).
52. Kawano, K. et al. Spontaneous long-term hyperglycemic rat with diabetic complications. Otsuka Long-Evans Tokushima Fatty (OLETF) strain. Diabetes 41, 1422-1428 (1992).
53. Funakoshi, A. et al. An animal model of congenital defect of gene expression of cholecystokinin (CCK)-A receptor. Biochem. Biophys. Res. Commun. 210, 787-796 (1995).
54. Shi, K., Mizuno, A., Sano, T., Ishida, K. & Shima, K. Sexual difference in the incidence of diabetes mellitus in Otsuka-Long-Evans-Tokushima- Fatty rats: effects of castration and sex hormone replacement on its incidence. Metabolism 43, 1214-1220 (1994). (Pubitemid 24307933)
55. Shimizu, H. et al. Orchiectomy and response to testosterone in the development of obesity in young Otsuka-Long-Evans-Tokushima Fatty (OLETF) rats. Int. J. Obes. Relat. Metab. Disord. 22, 318-324 (1998). (Pubitemid 28138437)
56. Efrat, S., Fleischer, N. & Hanahan, D. Diabetes induced in male transgenic mice by expression of human H-ras oncoprotein in pancreatic β cells. Mol. Cell Biol. 10, 1779-1783 (1990).
57. Efrat, S. Sexual dimorphism of pancreatic β-cell degeneration in transgenic mice expressing an insulin-ras hybrid gene. Endocrinology 128, 897-901 (1991).
58. Withers, D. J. et al. Disruption of IRS-2 causes type 2 diabetes in mice. Nature 391, 900-904 (1998). (Pubitemid 28157668)
59. Burks, D. J. et al. IRS-2 pathways integrate female reproduction and energy homeostasis. Nature 407, 377-382 (2000).
60. Withers, D. J. et al. Irs-2 coordinates Igf-1 receptor-mediated β-cell development and peripheral insulin signalling. Nat. Genet. 23, 32-40 (1999). (Pubitemid 29418784)
61. Kushner, J. A. et al. Pdx1 restores β cell function in Irs2 knockout mice. J. Clin. Invest. 109, 1193-1201 (2002). (Pubitemid 34496597)
62. Sorenson, R. L., Brelje, T. C. & Roth, C. Effects of steroid and lactogenic hormones on islets of Langerhans: a new hypothesis for the role of pregnancy steroids in the adaptation of islets to pregnancy. Endocrinology 133, 2227-2234 (1993). (Pubitemid 23324731)
63. Fehmann, H. C. & Habener, J. F. Insulinotropic hormone glucagon-like peptide-I(7-37) stimulation of proinsulin gene expression and proinsulin biosynthesis in insulinoma β TC-1 cells. Endocrinology 130, 159-166 (1992).
64. Holz, G. G. 4th, Kühtreiber, W. M. & Habener, J. F. Pancreatic β-cells are rendered glucose-competent by the insulinotropic hormone glucagon-like peptide-1(7-37). Nature 361, 362-365 (1993). (Pubitemid 23041630)
65. Covey, S. D. et al. The pancreatic β cell is a key site for mediating the effects of leptin on glucose homeostasis. Cell Metab. 4, 291-302 (2006). (Pubitemid 44430918)
66. Morioka, T. et al. Disruption of leptin receptor expression in the pancreas directly affects β cell growth and function in mice. J. Clin. Invest. 117, 2860-2868 (2007). (Pubitemid 47529616)
67. Wijesekara, N. et al. Adiponectin-induced ERK and Akt phosphorylation protects against pancreatic β cell apoptosis and increases insulin gene expression and secretion. J. Biol. Chem. 285, 33623-33631 (2010).
68. Holland, W. L. et al. Receptor-mediated activation of ceramidase activity initiates the pleiotropic actions of adiponectin. Nat. Med. 17, 55-63 (2011).
69. Lee, N. K. et al. Endocrine regulation of energy metabolism by the skeleton. Cell 130, 456-469 (2007). (Pubitemid 47208519)
70. Nadal, A. et al. Rapid insulinotropic effect of 17β-estradiol via a plasma membrane receptor. FASEB J. 12, 1341-1348 (1998). (Pubitemid 28475575)
71. Nadal, A. et al. Nongenomic actions of estrogens and xenoestrogens by binding at a plasma membrane receptor unrelated to estrogen receptor α and estrogen receptor β. Proc. Natl Acad. Sci. USA 97, 11603-11608 (2000).
72. Ropero, A. B., Soria, B. & Nadal, A. A nonclassical estrogen membrane receptor triggers rapid differential actions in the endocrine pancreas. Mol. Endocrinol. 16, 497-505 (2002). (Pubitemid 34214569)
73. Quesada, I. et al. Low doses of the endocrine disruptor bisphenol-A and the native hormone 17β-estradiol rapidly activate transcription factor CREB. FASEB J. 16, 1671-1673 (2002).
74. Contreras, J. L. et al. 17β-Estradiol protects isolated human pancreatic islets against proinflammatory cytokine-induced cell death: molecular mechanisms and islet functionality. Transplantation 74, 1252-1259 (2002). (Pubitemid 35402594)
75. Kang, L. et al. Involvement of estrogen receptor variant ER-α36, not GPR30, in nongenomic estrogen signaling. Mol. Endocrinol. 24, 709-721 (2010).
76. Revankar, C. M., Cimino, D. F., Sklar, L. A., Arterburn, J. B. & Prossnitz, E. R. A transmembrane intracellular estrogen receptor mediates rapid cell signaling. Science 307, 1625-1630 (2005). (Pubitemid 40354745)
77. Maggiolini, M. et al. The G protein-coupled receptor GPR30 mediates c-fos up-regulation by 17β-estradiol and phytoestrogens in breast cancer cells. J. Biol. Chem. 279, 27008-27016 (2004). (Pubitemid 38812536)
78. Toran-Allerand, C. D. et al. ER-X: a novel, plasma membrane-associated, putative estrogen receptor that is regulated during development and after ischemic brain injury. J. Neurosci. 22, 8391-8401 (2002). (Pubitemid 35387579)
79. Budhiraja, R. et al. Estrogen modulates xanthine dehydrogenase/xanthine oxidase activity by a receptor-independent mechanism. Antioxid. Redox. Signal. 5, 705-711 (2003). (Pubitemid 37462053)
80. Mann, V., Huber, C., Kogianni, G., Collins, F. & Noble, B. The antioxidant effect of estrogen and selective estrogen receptor modulators in the inhibition of osteocyte apoptosis in vitro. Bone 40, 674-684 (2007). (Pubitemid 46201947)
81. Yue, W. et al. Effects of estrogen on breast cancer development: Role of estrogen receptor independent mechanisms. Int. J. Cancer 127, 1748-1757 (2010).
82. Eckhoff, D. E. et al. Suppression of the c-Jun N-terminal kinase pathway by 17β-estradiol can preserve human islet functional mass from proinflammatory cytokine-induced destruction. Surgery 134, 169-179 (2003). (Pubitemid 37070336)
83. Liu, S. & Mauvais-Jarvis, F. Rapid, nongenomic estrogen actions protect pancreatic islet survival. Islets 1, 273-275 (2009).
84. Balhuizen, A., Kumar, R., Amisten, S., Lundquist, I. & Salehi, A. Activation of G protein-coupled receptor 30 modulates hormone secretion and counteracts cytokine-induced apoptosis in pancreatic islets of female mice. Mol. Cell Endocrinol. 320, 16-24 (2010).
85. Kumar, R., Balhuizen, A., Amisten, S., Lundquist, I. & Salehi, A. Insulinotropic and antidiabetic effects of 17β-estradiol and the GPR30 agonist G.-1 on human pancreatic islets. Endocrinology 152, 2568-2579 (2011).
86. Selye, H. Correlations between the chemical structure and the pharmacological actions of the steroids. Endocrinology 30, 437-453 (1942).
87. Szego, C. M. & Davis, J. S. Adenosine 3',5'-monophosphate in rat uterus: acute elevation by estrogen. Proc. Natl Acad. Sci. USA 58, 1711-1718 (1967).
88. Jensen, E. & Jacobson, H. Basic guides to the mechanism of estrogen action. Recent Prog. Horm. Res. 18, 387-414 (1962).
89. Behl, C. et al. Neuroprotection against oxidative stress by estrogens: structure-activity relationship. Mol. Pharmacol. 51, 535-541 (1997). (Pubitemid 27172978)
90. Yang, W., Wang, S., Li, L., Liang, Z. & Wang, L. Genistein reduces hyperglycemia and islet cell loss in a high-dosage manner in rats with alloxan-induced pancreatic damage. Pancreas 40, 396-402 (2011).
91. Bologa, C. G. et al. Virtual and biomolecular screening converge on a selective agonist for GPR30. Nat. Chem. Biol. 2, 207-212 (2006).
92. Baquie, M. et al. The liver receptor homolog-1 (LRH-1) is expressed in human islets and protects β-cells against stress-induced apoptosis. Hum. Mol. Genet. 20, 2823-2833 (2011).
93. Barnes, B. O., Regan, J. F. & Nelson, W. O. Improvement in experimental diabetes following the administration of ammniotin. JAMA 101, 926-927 (1933).
94. Nelson, W. O. & Overholser, M. D. The effect of oestrogenic hormone on experimental pancreatic diabetes in the monkey. Endocrinology 20, 473-480 (1936).
95. Rodriguez, R. R. in On the Nature and Treatment of Diabetes (eds Leibel, B. S. & Wrenshall, G. A.) 288-307 (Excerpta Medica Foundation, 1965).
96. Costrini, N. V. & Kalkhoff, R. K. Relative effects of pregnancy, estradiol, and progesterone on plasma insulin and pancreatic islet insulin secretion. J. Clin. Invest. 50, 992-999 (1971).
97. Choi, S. B., Jang, J. S. & Park, S. Estrogen and exercise may enhance β-cell function and mass via insulin receptor substrate 2 induction in ovariectomized diabetic rats. Endocrinology 146, 4786-4794 (2005). (Pubitemid 41446616)
98. Alonso-Magdalena, P., Morimoto, S., Ripoll, C., Fuentes, E. & Nadal, A. The estrogenic effect of bisphenol A disrupts pancreatic β-cell function in vivo and induces insulin resistance. Environ. Health Perspect. 114, 106-112 (2006). (Pubitemid 43056876)
99. Wong, W. P. et al. Extranuclear estrogen receptor-α stimulates NeuroD1 binding to the insulin promoter and favors insulin synthesis. Proc. Natl Acad. Sci. USA 107, 13057-13062 (2010).
100. Sutter-Dub, M. T. Preliminary report: effects of female sex hormones on insulin secretion by the perfused rat pancreas. J. Physiol. (Paris) 72, 795-800 (1976).
101. Senzen, S. Effects of ovariectomy and treatment with progesterone or oestradiol-17 β on the secretion of insulin by the perfused rat pancreas. J. Endocrinol. 78, 153-154 (1978).
102. Faure, A. & Sutter-Dub, M. T. Insulin secretion from isolated pancreatic islets in the female rat. Short and long term oestradiol influence. J. Physiol. (Paris) 75, 289-295 (1979). (Pubitemid 9214631)
103. Alonso-Magdalena, P. et al. Pancreatic insulin content regulation by the estrogen receptor ER α. PLoS ONE 3, e2069 (2008).
104. Horn, P. A. et al. Effect of estradiol on insulin secreting INS-1 cells overexpressing estrogen receptors. Eur. J. Endocrinol. 142, 84-91 (2000). (Pubitemid 30094205)
105. Magnaterra, R. et al. The effects of pregnancy steroids on adaptation of β cells to pregnancy involve the pancreatic glucose sensor glucokinase. J. Endocrinol. 155, 247-253 (1997). (Pubitemid 27475820)
106. Al-Majed, H. T. et al. Effect of 17β-estradiol on insulin secretion and cytosolic calcium in Min6 mouse insulinoma cells and human islets of Langerhans. Pancreas 30, 307-313 (2005). (Pubitemid 40586806)
107. Soriano, S. et al. Rapid regulation of K(ATP) channel activity by 17β-estradiol in pancreatic β-cells involves the estrogen receptor β and the atrial natriuretic peptide receptor. Mol. Endocrinol. 23, 1973-1982 (2009).
108. Mårtensson, U. E. et al. Deletion of the G protein-coupled receptor 30 impairs glucose tolerance, reduces bone growth, increases blood pressure, and eliminates estradiol-stimulated insulin release in female mice. Endocrinology 150, 687-698 (2009).
109. Sharma, G. & Prossnitz, E. R. Mechanisms of estradiol-induced insulin secretion by the G protein-coupled estrogen receptor GPR30/GPER in pancreatic β-cells. Endocrinology 152, 3030-3039 (2011).
110. D'Eon, T. M. et al. Estrogen regulation of adiposity and fuel partitioning. Evidence of genomic and non-genomic regulation of lipogenic and oxidative pathways. J. Biol. Chem. 280, 35983-35991 (2005). (Pubitemid 41633867)
111. Gao, H. et al. Long-term administration of estradiol decreases expression of hepatic lipogenic genes and improves insulin sensitivity in ob/ob mice: a possible mechanism is through direct regulation of signal transducer and activator of transcription 3. Mol. Endocrinol. 20, 1287-1299 (2006). (Pubitemid 43801232)
112. Takada, M. et al. Effects of explosive brain death on cytokine activation of peripheral organs in the rat. Transplantation 65, 1533-1542 (1998). (Pubitemid 28304585)
113. Contreras, J. L. et al. Brain death significantly reduces isolated pancreatic islet yields and functionality in vitro and in vivo after transplantation in rats. Diabetes 52, 2935-2942 (2003). (Pubitemid 37466863)
114. Eckhoff, D. E. et al. Enhanced isolated pancreatic islet recovery and functionality in rats by 17β-estradiol treatment of brain death donors. Surgery 136, 336-345 (2004). (Pubitemid 39037674)
115. Liu, S., Kilic, G. & Mauvais-Jarvis, F. Estrogens improve angiogenesis during pancreatic islet transplantation. Presented at the Keystone Symposia on advances in islet biology (Whistler, Canada, 2010).
116. Salonia, A. et al. Sexual function and endocrine profile in fertile women with type 1 diabetes. Diabetes Care 29, 312-316 (2006). (Pubitemid 44106510)
117. Codner, E. Estrogen and type 1 diabetes mellitus. Pediatr. Endocrinol. Rev. 6, 228-234 (2008).
118. Cooke, P. S. et al. Stromal estrogen receptors mediate mitogenic effects of estradiol on uterine epithelium. Proc. Natl Acad. Sci. USA 94, 6535-6540 (1997). (Pubitemid 27270720)
119. Houssay, B. A., Foglia, V. G. & Rodriguez, R. R. Production or prevention of some types of experimental diabetes by oestrogens or corticosteroids. Acta Endocrinol. (Copenh.) 17, 146-164 (1954).
120. Goodman, M. N. & Hazelwood, R. L. Short-term effects of oestradiol benzoate in normal, hypophysectomized and alloxan-diabetic male rats. J. Endocrinol. 62, 439-449 (1974).
121. Yamabe, N., Kang, K. S. & Zhu, B. T. Beneficial effect of 17β-estradiol on hyperglycemia and islet β-cell functions in a streptozotocin-induced diabetic rat model. Toxicol. Appl. Pharmacol. 249, 76-85 (2010).
122. Ren, Z., Zou, C., Ji, H. & Zhang, Y. A. Oestrogen regulates proliferation and differentiation of human islet-derived precursor cells through oestrogen receptor α. Cell Biol. Int. 34, 523-530 (2010).
123. Chlebowski, R. T. et al. Influence of estrogen plus progestin on breast cancer and mammography in healthy postmenopausal women: the Women's Health Initiative Randomized Trial. JAMA 289, 3243-3253 (2003). (Pubitemid 37430077)
124. Beral, V., Bull, D. & Reeves, G. Endometrial cancer and hormone-replacement therapy in the Million Women Study. Lancet 365, 1543-1551 (2005).
125. Kharode, Y., Bodine, P. V., Miller, C. P., Lyttle, C. R. & Komm, B. S. The pairing of a selective estrogen receptor modulator, bazedoxifene, with conjugated estrogens as a new paradigm for the treatment of menopausal symptoms and osteoporosis prevention. Endocrinology 149, 6084-6091 (2008).
126. Komm, B. S. A new approach to menopausal therapy: the tissue selective estrogen complex. Reprod. Sci. 15, 984-992 (2008).
127. Finan, B. et al. Estrogen conjugates of GLP-1 demonstrate enhanced efficacy in diet-induced obese mice. Presented at the Keystone Symposia on type 2 diabetes, insulin resistance and metabolic dysfunction (Keystone, CO, USA, 2011).
128. Nilsson, S. et al. Mechanisms of estrogen action. Physiol. Rev. 81, 1535-1565 (2001). (Pubitemid 32951806)
129. Levin, E. R. Plasma membrane estrogen receptors. Trends Endocrinol. Metab. 20, 477-482 (2009).
130. Verchere, C. B. et al. Islet amyloid formation associated with hyperglycemia in transgenic mice with pancreatic β cell expression of human islet amyloid polypeptide. Proc. Natl Acad. Sci. USA 93, 3492-3496 (1996). (Pubitemid 26125648)
131. Leiter, E. H., Chapman, H. D. & Coleman, D. L. The influence of genetic background on the expression of mutations at the diabetes locus in the mouse. V. Interaction between the db gene and hepatic sex steroid sulfotransferases correlates with gender-dependent susceptibility to hyperglycemia. Endocrinology 124, 912-922 (1989). (Pubitemid 19057087)